View on Peak SINGLEDosage chartEpithalon
Epithalamin Synthetic Analog
Glu-Asp-Arg (EDR) · synthetic tripeptide bioregulator
The reference protocol starts at 1 mg daily for days 1–5, then 1.5 mg for days 6–14 and 2 mg for days 15–20. A 20 mg vial plus 3 mL gives 6.67 mg/mL, so the 1 mg start is 15 units (0.15 mL) on a U-100 syringe.
Reviewed 25 Oct 2026 · Education only, not medical advice
Pinealon 20 mg vial
Not currently stocked by Peak Peptides Australia
No product photo — this strength isn't stocked by Peak
20-day daily approach · 20 mg vial + 3 mL BAC water
3 mL is the mix used by the attributed 20 mg reference protocol, giving 6.67 mg/mL.
| Days | Daily dose | Syringe units | Syringe fill |
|---|---|---|---|
| Days 1–5Start | 1 mg | 15 units0.15 mL | |
| Days 6–14 | 1.5 mg | 22.5 units0.225 mL | |
| Days 15–20Maintenance | 2 mg | 30 units0.3 mL |
Once daily · morning or early afternoon · subcutaneous injection
The attributed reference describes 10–20 day cycles and an optional extension to 28 days.
At the same reference, repeat cycles are spaced 2–3 months apart.
A full 20-day stepped schedule totals 30.5 mg, so it needs two 20 mg vials.
Reference-site educational amounts — Pinealon has no clinically established human dose in Australia or the United States. Education only, not medical advice. Dose amounts adapted from Pinealon 20 mg vial dosage protocol (PeptideDosages.com); units are recalculated for the vial and mix selected above.
Using a 1 mL (100-unit) insulin syringe, 3 full draws of bacteriostatic water gives 6.67 mg/mL.
1Wipe both rubber stoppers with an alcohol swab and let them dry. Draw 3 mL of bacteriostatic water and let it run slowly down the inside of the vial wall — not straight onto the powder.
2Swirl or roll the vial gently until the powder has dissolved. Give it a few minutes to settle if needed.
3Shaking can damage the peptide and cause foaming. Gentle swirling only.
4Only use it once it is fully clear with no particles. Label the vial with the date and 6.67 mg/mL, then store it in the fridge at 2–8 °C.
Counts follow the dosage chart above at the highest amount in each step, using a 20 mg vial mixed with 3 mL.
Plus an approved sharps container. Syringes and swabs are sold by Australian pharmacies — Peak Peptides and Pure Performance supply the bacteriostatic water.
Enter your vial, water and dose to see the matching syringe units.
Concentration
6.67 mg/mL
(6667 mcg/mL)
Calculated Liquid Volume
0.150 mL
Equivalent U-100 volume scale position
Illustration of a U-100 volume scale, not preparation or injection guidance
Pinealon, also called EDR, is a synthetic tripeptide with the sequence Glu-Asp-Arg.
Cell and rodent research has explored whether EDR affects oxidative-stress responses, cell survival and gene expression. These proposed mechanisms have not established a clinical benefit or a human dose.
Guidance: World Health Organization · National Diabetes Services Scheme (NDSS)
With 3 mL in a 20 mg vial, the concentration is 6.67 mg/mL. A 1 mg dose is 15 units, or 0.15 mL, on a U-100 syringe. At the same mix, 1.5 mg is 22.5 units (0.225 mL) and 2 mg is 30 units (0.30 mL).
The attributed 20 mg reference protocol uses 3 mL of bacteriostatic water. That produces 6.67 mg/mL, where 15 units equals 1 mg and 30 units equals 2 mg on a U-100 syringe.
At 1 mg once daily, 20 mg lasts 20 days. At 1.5 mg once daily it lasts about 13.3 days, and at 2 mg once daily it lasts 10 days. The complete 20-day stepped reference schedule totals 30.5 mg, so it requires two 20 mg vials.
View on Peak SINGLEDosage chartEpithalamin Synthetic Analog
View on Peak SINGLEDosage chartDelta Sleep-Inducing Peptide
Cited example and evidence context
View on Peak SINGLEDosage chartHeptapeptide Analog of ACTH